BTI
SUPN icon

Blue Trust Inc’s Supernus Pharmaceuticals SUPN Stock Holding History

Blue Trust Inc’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.09K Buy
+45
New +$2.16K ﹤0.01% 2172
2024
Q4 		– Sell
-24
Closed -$642 – 2938
2024
Q3 		$642 Buy
+24
New +$749 ﹤0.01% 2766

Other funds holding SUPN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

Blue Trust Inc's SUPN Position: Q2 2026 in Review

Blue Trust Inc opened a new position in Supernus Pharmaceuticals (SUPN) in Q2 2026: 45 shares worth $2.09K. The stake represents ﹤0.01% of the portfolio and ranks #2172 among its holdings. This is a return to the name: Blue Trust Inc previously reported a position in SUPN as recently as Q3 2024.

Blue Trust Inc first reported a position in SUPN in Q3 2024 and has held it in 2 quarters since. 334 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.

  • Blue Trust Inc held 45 shares of Supernus Pharmaceuticals worth $2.09K as of Q2 2026.
  • Supernus Pharmaceuticals was a new Blue Trust Inc position in Q2 2026.
  • Supernus Pharmaceuticals made up ﹤0.01% of Blue Trust Inc's portfolio in Q2 2026, its #2172 holding.
  • Blue Trust Inc first reported a position in Supernus Pharmaceuticals in Q3 2024 and has held it in 2 quarters since.
  • 334 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.

Based on Blue Trust Inc's 13F filing for Q2 2026, filed 21 Jul 2026.